Each box contain 1 aluminium strips of 6 tablets

Cefixime, a third-generation cephalosporin antibiotic, operates by inhibiting bacterial cell wall synthesis, showcasing a broad spectrum of activity against diverse bacterial infections. The addition of Clavulanic Acid , a beta-lactamase inhibitor enhances the effectiveness of Cefixime by preventing its degradation by bacterial enzymes, particularly beta-lactamases. This synergistic combination extends the spectrum of antibacterial coverage, making Zixif CV-325 a versatile solution for various infections. The tablet form ensures ease of administration, providing a reliable means for individuals seeking effective treatment for bacterial conditions. We offer this product under the brand name Zixif CV-325 tablets.

• Respiratory tract infections
• Urinary tract infections
• Skin and soft tissue infections
• Otitis media
• Sinusitis
• Community-acquired pneumonia

Cefixime and Clavulanate potassium tablets exert their therapeutic effects by combining cefixime, a third-generation cephalosporin antibiotic, with clavulanate potassium, a β-lactamase inhibitor. Cefixime inhibits bacterial cell wall synthesis, disrupting their structural integrity. Clavulanate potassium enhances cefixime's efficacy by inhibiting β-lactamase enzymes, which often confer resistance to antibiotics. This dual action results in the potentiation of antibacterial activity against a broader spectrum of pathogens, ensuring a more effective treatment of bacterial infections.

Absorption:

 Zixif CV-325 is well-absorbed following oral administration, allowing for effective systemic distribution.

Distribution: Both Cefixime and Clavulanic Acid are distributed widely throughout the body, targeting bacterial sites of infection.

Excretion: Cefixime undergoes partial metabolism in the liver, with the majority of the unchanged drug excreted in the urine. Clavulanic Acid is primarily excreted through renal elimination.

• Known hypersensitivity to cephalosporins or beta-lactamase inhibitors
• History of severe hypersensitivity reactions to penicillins or cephalosporins

Before using Zixif CV-325, consider the following precautions:

• Caution in patients with a history of gastrointestinal disease, particularly colitis
• Monitoring for signs of an allergic reaction during treatment
• Renal function should be assessed, especially in patients with pre-existing renal impairment

The medical information on this website is provided as an information resource only. The information on this website is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health provider or a medical practitioner in understanding any information or in applying information that you might have come across, on this website. Please note that it dangerous to take any medication without doctor’s prescription or professional advice from a registered health practitioner. Do not use this information in place of a visit, consultation or advice of your healthcare providers.